Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, vice president and chief financial officer, is scheduled to present a corporate update at the Baird 2014 Health Care Conference at 7:55 AM ET on Wednesday, September 3, 2014.
A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event.
ABOUT CERUS
Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for more information.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.
Contacts:
Lainie Corten, 925-288-6319
Senior Director,
Global Marketing & Investor Relations
